In glioblastomas, the growing list of candidate TAAs include the epidermal growth factor receptor (EGFR) [18], tenascin-C (TNC) [19], fatty acid binding protein 5 (FABP5) [20], melanoma-associated antigen 3 (MAGEA3) [21], glioma-expressed antigen 2 (GLEA2) [22, 23], and PHD finger protein 3 (PHF3) [23, 24]. The gene discussed is PHF20; the disease is glioblastoma.